• Ownership

Keith Regnante - Insider Trading & Ownership

Entity
Individual
Location
733 Concord Avenue, Cambridge, MA
Summary
The estimated net worth of Keith Regnante is at least $1.94M dollars as of February 19, 2025. Keith Regnante is the CHIEF FINANCIAL OFFICER of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $1.94M.
All Insider Reports
All Insider Reports

Ownership of Keith Regnante

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KROS Keros Therapeutics, Inc. Chief Financial Officer $1.94M Feb 18, 2025

Insider Transactions Reported by Keith Regnante:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.